Here you see a volatile pharma stock with fantastic earnings and only a single product. The volatile action over the summer attracts a well known shortseller who takes a heavy short and then issues a very negative "research report" that spooks a few big holders that throw their holdings on at market. Mr. short covers at a fantastic profit and probably goes long along with some smart money opportunists in October. These guys cash out at beginning of November leaving us at the Wave 4 low shown which is really a Wave 2 on a longer time frame. Now what?

Likely scenario is a good earnings report (and a new dividend) will attract more buyers. Financial news will shift from touting the disaster to some coverage about how it was all overdone, blah blah.

I'm guessing there is a good opportunity here.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.